Hackett Joanne M. 4
4 · AgeX Therapeutics, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Hackett Joanne M.
Director
Transactions
- Award
Option to Purchase Common Stock
2022-02-02+65,000→ 65,000 totalExercise: $0.83Exp: 2032-02-01→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Options will vest and become exercisable in four equal quarterly installments on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.